Patents Assigned to Merck Patents GmbH
  • PHARMACEUTICAL PREPARATION
    Publication number: 20230330027
    Abstract: The present invention relates to a solid pharmaceutical preparation of of 8-(1,3-Dimethyl-1 H-pyrazol-4-yl)-1-(Sa)-(3-fluoro-5-methoxy-pyridin-4-yl)-7-methoxy-3-methyl-1,3-dihydro-imidazo[4,5-c]quinolin-2-one, as well as a method of making same, as well as medical uses thereof.
    Type: Application
    Filed: September 15, 2021
    Publication date: October 19, 2023
    Applicant: MERCK PATENT GMBH
    Inventors: Alessandra AMBRUOSI, Riccardo MANNINI, Markus RIEHL, Axel BECKER
  • Liquid-crystalline medium for use in a switching element
    Patent number: 11788009
    Abstract: Liquid-crystalline media containing one or more mesogenic compounds, one or more chiral compounds, and one or more polymerizable mesogenic compounds, wherein the media exhibit a pitch of 0.55 ?m or more and a clearing point of 80° C. or more and wherein the one or more polymerizable mesogenic compounds are contained in an amount, based on the overall contents of the media, of 5% by weight or less, are suitable as modulation materials. Such modulation materials can be used in switching layers and window elements.
    Type: Grant
    Filed: December 3, 2018
    Date of Patent: October 17, 2023
    Assignee: MERCK PATENT GMBH
    Inventors: Paul Verbunt, Ties De Jong, Michael Junge, Mila Fischer
  • Connecting mechanism for a water purification cartridge
    Patent number: 11786867
    Abstract: A connecting mechanism (1) for a cartridge-type replaceable module (2) that has at least one fluid port (2a,2b) at each of opposite sides of the module (2) in a longitudinal direction of the module (2). The connecting mechanism (1) comprises two connector elements (3) spaced apart in the longitudinal direction of the module (2) and each provided with at least one fluid connector (3b) configured to releasably inter-engage with a complementary fluid port (2a,2b) of the module (2) at the respective side thereof, wherein at least one of the connector elements (3) is movable to perform a translational movement in the longitudinal direction of the module (2).
    Type: Grant
    Filed: April 28, 2021
    Date of Patent: October 17, 2023
    Assignee: Merck Patent GmbH
    Inventors: Pascal Roitel, Germain Gaydier, Thierry Cassou, Christian Berducat
  • LIQUID-CRYSTAL MEDIUM
    Publication number: 20230323209
    Abstract: The present invention relates to liquid-crystal (LC) media as defined in claim 1, having negative dielectric anisotropy and to the use thereof for optical, electro-optical and electronic purposes, in particular in LC displays.
    Type: Application
    Filed: April 11, 2023
    Publication date: October 12, 2023
    Applicant: MERCK PATENT GMBH
    Inventor: Jing WANG
  • ANTI-ALPHA-V INTEGRIN ANTIBODY FOR THE TREATMENT OF FIBROSIS AND/OR FIBROTIC DISORDERS
    Publication number: 20230322934
    Abstract: A method can treat a patient suffering from at least one of fibrosis and a fibrotic disorder. The method includes administering a therapeutically effective amount of an anti-?v integrin antibody DI17E6, or a biologically active variant or modification thereof, to the patient.
    Type: Application
    Filed: October 28, 2022
    Publication date: October 12, 2023
    Applicant: Merck Patent GmbH
    Inventors: Ilhan CELIK, Eike Staub, Miriam Urban, Sabine Raab-Westphal, Eileen Samy, Andrew Bender, Georgianna Varrone, Yin Wu, Daigen Xu
  • LIQUID-CRYSTALLINE MEDIUM
    Publication number: 20230323207
    Abstract: The present invention relates to a liquid-crystal material (LC media) comprising thiophene derivatives which are stabilised by sterically hindered amines or amine derivatives (HALS, hindered amine light stabilisers), and to liquid-crystal displays (LC displays) which contain these LC materials.
    Type: Application
    Filed: April 11, 2023
    Publication date: October 12, 2023
    Applicant: MERCK PATENT GMBH
    Inventors: Atsutaka MANABE, Rocco FORTTE, Harald HIRSCHMANN
  • Calibration device for an optical detector and setting device for setting calibration points for the calibration device
    Patent number: 11785683
    Abstract: The present invention provides a calibration device for an optical detector comprising a light emitting diode 1, and an electronic circuit 3 for driving the light emitting diode 1, wherein the electronic circuit 3 is a constant current generator configured to supply a constant driving current to the light emitting diode 1 in the range of 0.5 to 25 ?A. Furthermore, the present invention provides a setting device for setting at least one calibration point for a calibration device as described above. The setting device comprises a light detector 51 configured to output a signal representing the light emission intensity of a calibration device under examination, a controller 53 for controlling the constant driving current of the calibration device under examination, and a calibration point setting means 55 for setting at least one calibration point for the calibration device under examination.
    Type: Grant
    Filed: May 29, 2019
    Date of Patent: October 10, 2023
    Assignee: MERCK PATENT GmbH
    Inventors: Fabrice Comini, Frederick G. Bargoot, Victor Etre
  • Liquid-crystal medium
    Patent number: 11781069
    Abstract: The present invention relates to an LC medium comprising and a liquid-crystalline host consisting of an LC component H) comprising one or more mesogenic or liquid-crystalline compounds and an optically active component D) and optionally a polymerizable component P) comprising one or more polymerizable compounds; and to the use of the polymerizable compounds and LC media for optical, electro-optical and electronic purposes, in particular in LC displays, especially in LC displays of the polymer sustained alignment type.
    Type: Grant
    Filed: December 19, 2018
    Date of Patent: October 10, 2023
    Assignee: MERCK PATENT GMBH
    Inventor: Kirsten (Min-Chu) Liao
  • DEVICE AND PROCESS FOR CELL CULTURE MEDIA PREPARATION AND PERFORMING CELL CULTURE
    Publication number: 20230313109
    Abstract: The present invention relates to a device and processes for producing liquid media for cell cultures, whereby the liquid media are produced automatically by dissolving ingredients in water. The present invention also relates to a device for producing media used in cell cultures or a substance produced by cell cultures using a bioreactor process.
    Type: Application
    Filed: July 5, 2021
    Publication date: October 5, 2023
    Applicant: Merck Patent GmbH
    Inventors: Jochen Bastian SIECK, Christian SCHULTHEISS
  • DEVICE
    Publication number: 20230320140
    Abstract: The present invention relates to a color conversion device (100).
    Type: Application
    Filed: September 1, 2021
    Publication date: October 5, 2023
    Applicant: MERCK PATENT GMBH
    Inventors: Tadashi KISHIMOTO, Atsuko NOYA, Julian BURSCHKA, Teruaki SUZUKI, Daishi YOKOYAMA, Seishi SHIBAYAMA
  • SYSTEM FOR TREATING A BIOTECHNOLOGICAL FLUID
    Publication number: 20230313114
    Abstract: The present application relates to biotechnological fluid treating, such as biopharmaceutical liquids in order to obtain products such as monoclonal antibodies, vaccines or recombinant proteins, and particularly to a system for treating a biotechnical fluid, having a bioprocess machine and at least one bioprocess machine helper, configured to connect to each other and each comprising a controller, in turn comprising a machine-to-machine communication tool configured for connecting to a network.
    Type: Application
    Filed: August 19, 2021
    Publication date: October 5, 2023
    Applicant: MERCK PATENT GMBH
    Inventors: Rene REINBIGLER, Denis DUBRET, Steve MILLER
  • METAL COMPLEXES
    Publication number: 20230320191
    Abstract: The present invention relates to iridium complexes suitable for use in organic electroluminescent devices, especially as emitters.
    Type: Application
    Filed: May 19, 2023
    Publication date: October 5, 2023
    Applicant: Merck Patent GmbH
    Inventors: Philipp Stoessel, Armin Auch
  • AGGRECAN BINDING IMMUNOGLOBULINS
    Publication number: 20230312694
    Abstract: The present invention relates to immunoglobulins that specifically bind Aggrecan and more in particular to polypeptides, nucleic acids encoding such polypeptides; to methods for preparing such polypeptides; to compositions and in particular to pharmaceutical compositions that comprise such polypeptides, for prophylactic, therapeutic or diagnostic purposes. In particular, the immunoglobulins of the present invention inhibit the activity of Aggrecan.
    Type: Application
    Filed: December 23, 2022
    Publication date: October 5, 2023
    Applicants: Ablynx N.V., Merck Patent GmbH
    Inventors: Soren Steffensen, Gerald Beste, Guy Hermans, Hans Gühring, Christoph Ladel, Lars Toleikis
  • OPTICAL COMPONENT
    Publication number: 20230313043
    Abstract: The present invention relates to an optical component comprising a liquid crystal (LC) medium, operable in the infrared region of the electromagnetic spectrum. The invention further relates to the use of said LC medium in the infrared (IR) region and to devices comprising said optical component. The present invention further relates to an LC medium comprising one or more compounds of the formulae I, II, and III in which the occurring groups and parameters have the meanings defined in claim 1, and preferably one or more compounds of the formula RO in which the occurring groups and parameters have the meanings defined in claim 2.
    Type: Application
    Filed: July 6, 2021
    Publication date: October 5, 2023
    Applicant: Merck Patent GmbH
    Inventors: Izumi SAITO, Owain Llyr PARRI, Andreas TAUGERBECK, Carsten FRITZSCH, Dagmar KLASS
  • Composition for organic electronic devices
    Patent number: 11778907
    Abstract: The present invention relates to a composition comprising a bipolar host and an electron-transporting host, especially for use as matrix material in electronic devices, especially organic electroluminescent devices, and especially in an organic light-emitting diode (OLED). The invention further relates to electronic devices comprising said composition.
    Type: Grant
    Filed: April 10, 2018
    Date of Patent: October 3, 2023
    Assignee: Merck Patent GmbH
    Inventors: Amir Parham, Jonas Kroeber, Christian Eickhoff, Tobias Grossmann, Aurélie Ludemann, Dominik Joosten
  • Polypeptides that bind to IL-17A, IL-17F and/or IL17-A/F and methods of treatment using same
    Patent number: 11773159
    Abstract: The present disclosure relates to amino acid sequences that are directed against (as defined herein) any of IL-17A, IL-17F and/or IL-17A/F including combinations thereof, as well as to compounds or constructs, and in particular proteins and polypeptides, that comprise or essentially consist of one or more such amino acid sequences.
    Type: Grant
    Filed: September 29, 2020
    Date of Patent: October 3, 2023
    Assignee: Merck Patent GmbH
    Inventors: Heidi Rommelaere, Joost Alexander Kolkman, Michael John Scott Saunders, Ann Union, Yolande Chvatchko, Amanda E. I. Proudfoot, Alain Vicari, Denis Bruniquel, Laurent Chevalet, Olivier Leger
  • Effect pigments
    Patent number: 11773270
    Abstract: The present invention relates to effect pigments which are based on flake-form substrates having a circular form factor of 1.2-2 and are coated with at least one high-refractive-index layer, and to the use thereof, inter alia in paints, coatings, printing inks, plastics and in cosmetic formulations.
    Type: Grant
    Filed: July 6, 2020
    Date of Patent: October 3, 2023
    Assignee: MERCK PATENT GMBH
    Inventors: Gerhard Pfaff, Stephanie Andes, Klaus Ambrosius, Ralf Petry, Michael Roesler, Sabine Schoen
  • COMPOUNDS FOR THE TREATMENT OF VIRAL INFECTIONS
    Publication number: 20230301991
    Abstract: The present invention encompasses ATR inhibitor for use in the treatment of coronavirus infections, including COVID-19, alone or in combination with one or more additional therapeutic agents.
    Type: Application
    Filed: October 22, 2021
    Publication date: September 28, 2023
    Applicant: MERCK PATENT GMBH
    Inventors: Ulrich BETZ, Thomas FUCHSS
  • TLR7/8 ANTAGONISTS AND USES THEREOF
    Publication number: 20230301981
    Abstract: Compounds disclosed herein and pharmaceutically acceptable compositions thereof are useful as TLR7/8 antagonists.
    Type: Application
    Filed: June 1, 2021
    Publication date: September 28, 2023
    Applicant: Merck Patent GmbH
    Inventors: Lukas Shinji Okitsu, Julie DeMartino, Thomas Spangenberg
  • Fluorine compounds
    Patent number: 11767396
    Abstract: The present invention relates to fluorine compounds (I), (II) and (III), to processes for the preparation thereof, and to the use thereof.
    Type: Grant
    Filed: June 24, 2021
    Date of Patent: September 26, 2023
    Assignee: Merck Patent GmbH
    Inventors: Reiner Friedrich, Fabian Koch